Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
12/2010
12/14/2010US7851625 Process for preparing 2,3-disubstituted indoles
12/14/2010US7851500 tyrosine kinase inhibitors such as Ethyl 3-(3-(pyrrolo[1,2-f][1,2,4]triazin-4-ylamino)-1H-pyrazol-5-ylthio)benzoate, useful as anticarcinogenic or antiproliferative agents
12/14/2010US7851475 3-(1H-indol-3-yl)-4-[5-(4-methyl-piperazin-1-yl)-2-nitro-phenyl]-pyrrole-2,5-dione, useful in the treatment of transplant rejection, graft versus host diseases, restenosis, obesity, syndrome X, diabetes, polycystic ovary syndrome, hypertension, cardiovascular or respiratory system disorders
12/14/2010US7851473 fatty acid amide hydrolase inhibitors such as N-(2-Chlorophenyl)-4-(3-phenyl-1,2,4-thiadiazol-5-yl)piperazine-1-carboxamide, used for the prophylaxis of brain, psychological or sleep disorders, as neuroprotectants, analgesics, antidepressants or anxiolytic agents
12/14/2010CA2470480C Indolinone derivatives useful as protein kinase inhibitors
12/14/2010CA2437944C Acylated indanyl amines and their use as pharmaceuticals
12/14/2010CA2400124C Tnf-.alpha. inhibitors
12/14/2010CA2159546C Cycloalkano-indole and -azaindole derivatives
12/09/2010WO2010141932A1 Aminopyrrolidinone derivatives and uses thereof
12/09/2010WO2010141805A1 Heterocyclic amides as modulators of trpa1
12/09/2010WO2010141424A1 Carbamate and urea inhibitors of 11beta-hydroxysteroid dehydrogenase 1
12/09/2010WO2010141406A2 Amino pyrimidine anticancer compounds
12/09/2010WO2010140802A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same
12/09/2010WO2010140139A2 Crystalline forms of 6- ( 1h- imidazol- 1-yl) -2-phenylquinazoline and salts thereof
12/09/2010WO2010139967A1 Dihydroindole and tetrahydroisoquinoline derivatives useful as potassium channel inhibitors
12/09/2010WO2010139953A1 Compounds
12/09/2010US20100311966 Imidazole carbonyl compound
12/09/2010US20100311965 2-aminoquinazoline derivative
12/09/2010US20100311754 1,4-Disubstituted Naphthalenes as Inhibitors of P38 Map Kinase
12/09/2010US20100311752 Substituted pyridazine derivatives
12/09/2010US20100311750 Organic compounds
12/09/2010US20100311749 4-benzoyl-1-substituted-piperazin-2-one derivatives as p2x7 modulators
12/09/2010US20100311747 Dicycloazaalkane derivates, preparation processes and medical uses thereof
12/09/2010US20100311745 1,3-dihydroisoindole derivatives
12/09/2010US20100311744 Novel 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, cx3cr1 and p40
12/09/2010US20100311715 Alpha carbolines and uses thereof
12/09/2010US20100311713 Novel Azetidine Compounds Useful in the Treatment of Functional Gastrointestinal Disorders, Ibs and Functional Dyspepsia
12/09/2010US20100311709 2-[1-PHENYL-5-HYDROXY OR METHOXY-4ALPHA-METHYL-HEXAHYDROCYCLOPENTA [f]INDAZOLE-5-YL]ETHYL PHENYL DERIVATIVES AS GLUCOCORTICOID RECEPTOR LIGANDS
12/09/2010US20100310870 Amorphous bazedoxifene acetate and preparation thereof
12/09/2010US20100310668 Pharmaceutical compositions comprising n-[2-(diethylamino)ethyl]-5-[(5-fluoro-1,2-dihydro-2-oxo-3h-indol-3-ylidene)methyl]-2,4-dimethyl-1h-pyrrole-3-carboxamide
12/09/2010US20100310512 Antiviral compounds
12/09/2010CA2764387A1 Aminopyrrolidinone derivatives and uses thereof
12/09/2010CA2762307A1 Crystalline forms of 6-(1h-imidazol-1-yl)-2-phenylquinazoline and salts thereof
12/09/2010CA2757083A1 Amino pyrimidine anticancer compounds
12/08/2010EP2258776A1 Fluorescent cyanine dyes containing functional groups
12/08/2010EP2258699A1 Polymorphs of a pyrrole-substituted 2-Indolinone protein kinase inhibitor
12/08/2010EP2258690A1 Tricyclic amines as intermediates in the synthesis of fungicidal carboxamide derivatives
12/08/2010EP2257547A1 Novel benzimidazole linked pyrroloý2,1-qý1,4¨benzodiazepine hybrids as potential antitumour agents and process for the preparation thereof
12/08/2010EP2257546A2 Functionally selective alpha2c adrenoreceptor agonists
12/08/2010EP2257545A1 Pyrrolidinyl derivatives and uses thereof
12/08/2010EP2257541A1 Modulators for amyloid beta
12/08/2010EP2257539A1 Substituted 4-hydroxypyrimidine-5-carboxamides
12/08/2010EP2257534A1 3-aminoalkyl-1,4-diazepan-2-one melanocortin-5 receptor antagonists
12/08/2010EP2257533A1 3-substituted-1,4-diazepan-2-one melanocortin-5 receptor antagonists
12/08/2010EP2257297A1 Methods of modulating the activity of the mc5 receptor and treatment of conditions related to this receptor
12/08/2010EP2257167A1 2-aminoimidazole beta-secretase inhibitors for the treatment of alzheimer's disease
12/08/2010EP2150548B1 Process for hcv protease inhibitor intermediate
12/08/2010CN1671696B Kinase inhibitors
12/08/2010CN101910157A Indole compounds and methods for treating visceral pain
12/08/2010CN101910155A Biphenyl derivatives as modulators of the histamine-H3 receptor useful for the treatment of disorders related thereto
12/08/2010CN101910154A 5-lipoxygenase activating protein (FLAP) inhibitor
12/08/2010CN101910152A 4-pyrazolyl-N-arylpyrimidin-2-amines and 4-pyrazolyl-N-heteroarylpyrimidin-2-amines as janus kinase inhibitors
12/08/2010CN101910142A Modulators for amyloid beta
12/08/2010CN101210073B Composition containing bismaleimide oligomer and preparing method thereof
12/08/2010CN101087777B Pyrrolidinium derivatives as M3 muscarinic receptors
12/07/2010US7846962 3-(5-tert-Butyl-2-Hydroxy-phenyl)-3-phenyl-1,3-dihydro-indol-2-one and/or its derivatives, used for the treatment of cellular proliferative disorders, non-proliferative, degenerative disorders, viral infections, and/or disorders associated with viral infections
12/07/2010US7846959 Raf modulators and methods of use
12/07/2010US7846956 Malononitrile compound as pesticides
12/07/2010US7846933 such as 1-(4-Fluorophenyl)-5-(pyridin-4-yl)-4-imidazolin-2-one, having excellent p38 MAP kinase inhibitory action, useful for the treatment of osteoarthritis, arthritis, ulcerative colitis, Crohn's disease, psoriasis, dermatitis, asthma, bronchitis, pneumonia, rhinitis, conjunctivitis or keratitis
12/07/2010US7846924 Cyanopyrroles
12/07/2010US7846922 1-(isopropyl)-4-{[4-(tetrahydro-2H-pyran4-yloxy)phenyl]carbonyl}hexahydro-1H-1,4-diazepine, used in the treatment of nervous system and psychological disorders such as Alzheimer's disease or as cognition activators
12/07/2010US7846920 Bactericides; bacteriostats; therapy for bacteria infections
12/07/2010CA2471883C Phenylpyrimidine amines as ige inhibitors
12/02/2010WO2010138791A1 Antiviral compounds composed of three linked aryl moieties to treat diseases such as hepatitis c
12/02/2010WO2010138790A1 Antiviral compounds composed of three aligned aryl moieties to treat diseases such as hepatitis c
12/02/2010WO2010138720A2 Compounds and methods for chelating metals in aqueous solutions
12/02/2010WO2010138578A1 Pyrimidine inhibitors of kinase activity
12/02/2010WO2010138575A1 Pyrimidine inhibitors of kinase activity
12/02/2010WO2010138488A1 Hepatitis c virus inhibitors
12/02/2010WO2010138368A1 Hepatitis c virus inhibitors
12/02/2010WO2010137689A1 Novel pharmaceutical composition for prevention and/or treatment of attention deficit/hyperactivity disorder
12/02/2010WO2010136804A1 Pyrimidine derivatives for use as antibiotics
12/02/2010WO2010136755A1 Substituted benzotriazines and quinoxalines as inhibitors of p7os6 kinase
12/02/2010WO2010136458A1 Process for the preparation of n-[2-diethylamino)ethyl]-5-[(5-fluoro-1,2-dihydro-2-oxo-3h-indol-3-ylidene)methyl]-2,4-dimethyl-1h-pyrrole-3-carboxamide
12/02/2010WO2010136145A1 Pyrazinylpyrazoles
12/02/2010WO2010136109A1 Materials for organic electroluminescent devices
12/02/2010WO2010116386A3 Novel polymorph of eletriptan hydrobromide and process for the preparation thereof
12/02/2010WO2010106269A3 Derivatives of n-[(2-aza-bicyclo[2.1.1]hex-1-yl)-aryl-methyl]-heterobenzamide, preparation thereof and application of same in therapeutics
12/02/2010WO2010083384A3 Non-peptidyl, potent, and selective mu opioid receptor antagonists
12/02/2010WO2009118596A3 Phthalimide derivatives as trpa1 modulators
12/02/2010WO2009084029A3 Improved process for the preparation of (2r,3s)-2-(2,4- difluqrophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1h-1,2,4-triazol-1-yl) butan-2-ol
12/02/2010WO2009084028A3 Improved process for manufacturing anhydrous (e)-3-[2-butyl-1- {(4-carboxyphenyl) methyl}-1h-imidazole-5-yl]-(thiophen-2- ylmethyl)prop-2-enoic acid methane sulfonate
12/02/2010US20100305324 Pharmaceutical composition for preventing or treating osteoporosis or obesity comprising phenyltetrazole derivative
12/02/2010US20100305200 Compounds that modulate intracellular calcium
12/02/2010US20100305141 Tetrahydroindolone derivatives for treatment of neurological conditions
12/02/2010US20100305140 Benzimidazole derivatives which are to be used as antagonist for the cb1-receptor
12/02/2010US20100305137 Piperazine derivatives and methods of use
12/02/2010US20100305133 Prolyl Hydroxylase Inhibitors
12/02/2010US20100305128 Pyrimidinyl-Thiophene Kinase Modulators
12/02/2010US20100305126 Pyrimidine Inhibitors of Kinase Activity
12/02/2010US20100305119 Method for the treatment of anthrax infections
12/02/2010US20100305112 Pyrimidine inhibitors of kinase activity
12/02/2010US20100305100 Methods for treating hepatitis c
12/02/2010US20100305089 Fused Bicycloheterocycle Substituted Azabicyclic Alkane Derivatives
12/02/2010US20100305085 Substituted dihydropyrazolones for treating cardiovascular and hematological diseases
12/02/2010US20100305065 Use of 4-(pyrrolidin-1-yl)quinoline compounds to kill clinically latent microorganisms
12/02/2010US20100303755 Hepatitis C Virus Inhibitors
12/02/2010US20100303727 Optical imaging agents
12/02/2010US20100301313 Benzanthracene compound and organic electroluminescence device using the same
12/02/2010US20100301277 Imidazole Derivatives and Their use as Dopants for Doping an Organic Semiconductor Matrix Material
1 ... 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 ... 626